TMEM169
Transmembrane protein 169
Also known as: FLJ34263, TM169_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96HH4
- Gene
- TMEM169
- Ensembl
- ENSG00000163449
- Chromosome
- 2
- Canonical length
- 297 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Focal adhesion sites
OverviewNCBI Gene
Predicted to be located in membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
297 residues, UniProt reviewed canonical sequence.
>Q96HH4|TMEM169
1 MEEPTAVEGQ VQLPSPHQGS LRKAVAAALA LDGESTMGHR KKKRKESRPE SIIIYRSDNE
61 KTDEEPGESE GGDQPKEEEG DDFLDYPVDD DMWNLPLDSR YVTLTGTITR GKKKGQMVDI
121 HVTLTEKELQ ELTKPKESSR ETTPEGRMAC QMGADRGPHV VLWTLICLPV VFILSFVVSF
181 YYGTITWYNI FLVYNEERTF WHKISYCPCL VLFYPVLIMA MASSLGLYAA VVQLSWSWEA
241 WWQAARDMEK GFCGWLCSKL GLEDCSPYSI VELLESDNIS STLSNKDPIQ EVETSTVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TMEM169 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 2
- Mean surface accessibility (rSASA)
- 0.51
- Highest tissue expression
- 5.9 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 5.9 nTPM
- cerebellum: 3.5 nTPM
- retina: 3.2 nTPM
- spinal cord: 2.7 nTPM
- thyroid gland: 2.4 nTPM
- hypothalamus: 2.3 nTPM
Single-cell type
- cone photoreceptor cells: 33 nCPM
- renal collecting duct principal cells: 25 nCPM
- oligodendrocyte progenitor cells: 24 nCPM
- retinal bipolar cells: 23 nCPM
- retinal ganglion cells: 19 nCPM
- myosatellite cells: 17 nCPM
Immune cell
- T-reg: 3.7 nTPM
- non-classical monocyte: 3.3 nTPM
- neutrophil: 2.3 nTPM
- naive CD4 T-cell: 2.1 nTPM
- memory CD4 T-cell: 2 nTPM
- memory B-cell: 1.5 nTPM
Brain region
- cerebral cortex: 11 nTPM
- pons: 10 nTPM
- white matter: 10 nTPM
- hypothalamus: 9 nTPM
- hippocampal formation: 8.9 nTPM
- midbrain: 8.9 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.89
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 0.3
- DepMap mean gene effect
- 0
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
- TMEM169 protein
- TMEM169 protein family
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TMEM169 as an antibody target. Whether an autoantibody or antibody against TMEM169 could matter depends on whether native TMEM169 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TMEM169 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TMEM169 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...